Inactive Instrument

Merrion Pharmaceuticals Plc Stock

Equities

Duration

Period

Style

Merrion Pharmaceuticals : Notice of General meetings	16-08-26	PU
Merrion Pharmaceuticals : Proposed liquidation	16-08-23	PU
Merrion Pharmaceuticals : Disposal Completion	15-12-17	PU
Merrion Pharmaceuticals : Interim results for the six month period ended 30 June 2015, Dublin, Ireland 30 September 2015	15-10-01	PU
Merrion Pharmaceuticals : Announces Continuing Progress of Oral Insulin Projects Using Merrion Pharmaceuticals' GIPET Technology under license to its partner Novo Nordisk A/S	15-09-02	PU

Sector

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.27%	4.81B